HIF1A and lung cancer: miR-23a directly inhibits its targets, prolyl hydroxylases 1 and 2 (PHD1 and 2), in exosomes from lung cancer cells, resulting in the accumulation of hypoxia-inducible factor 1 alpha (HIF-1α) in endothelial cells.